Defective early B cell tolerance checkpoints in patients with systemic sclerosis allow the production of self-antigen-specific clones.

Defective counterselection of developing autoreactive naïve B cells in SSc leads to the production of self-antigen specific B cells that may secrete autoantibodies and allow the formation of immune complexes, which promote fibrosis in SSc.